American Riviera
You are here:  Home  >  Biotech  >  Current Article

Atara immunotherapy for mesothelioma promising

By   /   Wednesday, June 5th, 2019  /   Comments Off on Atara immunotherapy for mesothelioma promising

    Print       Email
New data presented by Memorial Sloan Kettering at the American Society of Clinical Oncology in Chicago June 4 showed promising results for mesothelioma patients with solid tumors who were given a new immunotherapy from Atara Biotherapeutics. The CAR T therapy targeting mesothelin was delivered along with chemotherapy. The results ”reaffirm mesothelin as a promising target…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Community Bank of Santa Maria reports income, asset growth

Read More →